0.742
price up icon3.90%   0.0279
 
loading

Finanzdaten der Vaxart Inc-Aktie (VXRT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
32.79%
2.181
3.245 2.101 1.358 0.675
Operating Expenses
30.31%
26.25
20.14 19.92 24.41 26.25
Benefits Costs and Expenses
29.87%
26.55
20.45 19.46 23.89 25.79
Costs And Expenses
29.87%
26.55
20.45 19.46 23.89 25.79
Depreciation and Amortization
6.61%
2.177
2.331 2.065 2.166 2.062
Operating Income/Loss
42.43%
-24.07
-16.90 -17.82 -23.05 -25.57
Income/Loss From Continuing Operations Before Tax
41.69%
-24.37
-17.20 -17.36 -22.53 -25.11
Income Tax Expense/Benefit
74.14%
0.045
0.174 0.039 0.019 0.029
Income/Loss From Continuing Operations After Tax
40.53%
-24.42
-17.38 -17.40 -22.55 -25.14
Net Income/Loss
40.53%
-24.42
-17.38 -17.40 -22.55 -25.14
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
17,145%
168.81
-0.9904 152.03 139.59 135.21
Basic Earnings Per Share
16.67%
-0.14
-0.12 -0.11 -0.16 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.48
price down icon 0.51%
$21.12
price up icon 2.45%
$355.15
price up icon 0.72%
$5.04
price down icon 0.59%
biotechnology ONC
$228.37
price up icon 2.52%
$122.21
price up icon 4.33%
Kapitalisierung:     |  Volumen (24h):